Health Catalyst HCAT Estimates

NASDAQ HCAT
$1.69 -0.02 (-1.17%)
At close: Sep 4, 2026 · 4:00 PM EDT
Analyst Estimates

Health Catalyst, Inc. Revenue Estimates

Periods 22
Next Period Q3 26
Consensus 57.19 M

Analysts expect Health Catalyst, Inc. to report revenue of 57.19 M for Q3 26, against a range of 53.69 M to 60.69 M. The most recent reported quarter, Q2 26, came in at 70.49 M, a 7.7% beat against the 65.45 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29
Reported (Actual) 76.35 M79.61 M79.41 M80.72 M76.32 M74.68 M70.76 M70.49 M--------
High Estimate 84.75 M87.63 M83.16 M93.40 M87.13 M75.17 M68.04 M68.45 M60.69 M50.89 M55.56 M53.37 M45.76 M44.79 M65.01 M62.40 M
Low Estimate 77.10 M78.18 M71.43 M77.78 M72.76 M67.77 M62.67 M62.44 M53.69 M44.96 M52.13 M47.46 M42.41 M37.17 M54.07 M51.37 M
Consensus Estimate 80.93 M82.90 M77.30 M85.59 M79.95 M71.47 M65.36 M65.45 M57.19 M47.93 M53.85 M50.42 M44.09 M40.98 M59.54 M56.88 M
Analyst Estimates

Health Catalyst, Inc. Earnings Per Share (EPS) Estimates

Periods 22
Next Period Q3 26
Consensus -0.05

Analysts expect Health Catalyst, Inc. to report earnings per share of -0.05 for Q3 26, against a range of -0.05 to -0.05. The most recent reported quarter, Q2 26, came in at 0.04, a 33.3% beat against the 0.03 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29
Reported (Actual) 0.070.040.010.040.060.080.020.04--------
High Estimate 0.090.070.000.030.060.090.010.03-0.05-0.050.010.01-0.05-0.060.030.07
Low Estimate 0.090.070.000.030.060.070.010.03-0.05-0.050.010.01-0.05-0.060.030.05
Consensus Estimate 0.090.070.000.030.060.080.010.03-0.05-0.050.010.01-0.05-0.060.030.06